This content is machine translated Study Report Ginkgo biloba and rivaroxaban: no indication of relevant interactions Ginkgo-containing preparations can alleviate neuropsychiatric complaints and are widely used, especially for the treatment of cognitive performance deficits. But what about the combinability with anticoagulant agents? In a recently published…
View Post 5 min This content is machine translated ESC Congress 2017, Barcelona Prevention of atrial fibrillation and complications The epidemic scale and serious complications make atrial fibrillation a major threat to cardiovascular health. In addition to vitamin K antagonists, four new oral anticoagulants (NOAKs) are available for stroke…
View Post 5 min This content is machine translated Coagulation tests Methods of choice for direct oral anticoagulants. DOAK affect routine coagulation tests to an extent that varies depending on the substance, the time of measurement, and the test system used. However, a statement about the strength of…
View Post 4 min This content is machine translated ACC Congress in San Diego “Universal antidote” of the future? An antidote to Factor Xa inhibitors is making great progress in clinical trials: Andexanet alfa. New results were presented at the American College of Cardiology Congress in San Diego: According…
View Post 7 min This content is machine translated Interventions in angiology Beyond the horizon it goes on… Catheter-based therapy for vascular disease has changed significantly in recent years. Rapid technical progress and greater clinical experience now allow recanalization of even severely calcified and long-stretch arterial occlusions. A…
View Post 7 min This content is machine translated Cardiology Highlights 2013 New practice-relevant European guidelines What news did the 2013 European Congress of Cardiology in Amsterdam bring? Discussed were not only practice-relevant guidelines, but also the current trends regarding lifestyle modifications. Furthermore, studies on the…
View Post 6 min This content is machine translated Acute pulmonary embolism Diagnostics and therapy The third leading cause of cardiovascular disease death is acute pulmonary embolism. The determination of D-dimers is highly sensitive in the exclusion of acute pulmonary embolism. CT angiography is nowadays…
View Post 6 min This content is machine translated Current overview New Anticoagulants in Prevention and Therapy of Thromboembolism The standard treatment for acute venous thromboembolism currently includes parenteral heparin administration, overlapping with the administration of a vitamin K antagonist (VKA). New oral anticoagulants (NOACs) and VKAs show different…
